# FDA recall D-0668-2017

> **Mckesson Medical Surgical** · Class II · drug recall initiated 2017-03-08.

## Product

hydrALAZINE HYDROCHLORIDE INJECTION, USP, 20 mg/mL, 1 mL Single Dose Vial, packaged in 25 Vials per carton, Rx only, APP Fresenius Kabi USA, LLC, Lake Surich, IL  60047, NDC 63323-614-01, Distributed by McKesson Medical-Surgical, Inc.

## Reason for recall

Temperature Abuse: Certain pieces of these lots distributed by McKesson Medical Surgical Inc. were inadvertently stored refrigerated rather than the labeled room temperature recommendation.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0668-2017
- **Recalling firm:** Mckesson Medical Surgical
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-03-08
- **Report date:** 2017-04-19
- **Termination date:** 2024-08-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Henrico, VA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0668-2017

## Citation

> AI Analytics. FDA recall D-0668-2017. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0668-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*